JP2002527401A5 - - Google Patents

Download PDF

Info

Publication number
JP2002527401A5
JP2002527401A5 JP2000575522A JP2000575522A JP2002527401A5 JP 2002527401 A5 JP2002527401 A5 JP 2002527401A5 JP 2000575522 A JP2000575522 A JP 2000575522A JP 2000575522 A JP2000575522 A JP 2000575522A JP 2002527401 A5 JP2002527401 A5 JP 2002527401A5
Authority
JP
Japan
Prior art keywords
fgf
composition
seq
unit dose
mutein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000575522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002527401A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/022936 external-priority patent/WO2000021548A2/en
Publication of JP2002527401A publication Critical patent/JP2002527401A/ja
Publication of JP2002527401A5 publication Critical patent/JP2002527401A5/ja
Withdrawn legal-status Critical Current

Links

JP2000575522A 1998-10-13 1999-10-13 Ｆｇｆの脈管形成的に有効な単位用量および投与方法 Withdrawn JP2002527401A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10410398P 1998-10-13 1998-10-13
US60/104,103 1998-10-13
PCT/US1999/022936 WO2000021548A2 (en) 1998-10-13 1999-10-13 Angiogenically effective unit dose of fgf and method of administering

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010043385A Division JP2010174017A (ja) 1998-10-13 2010-02-26 Ｆｇｆの脈管形成的に有効な単位用量および投与方法

Publications (2)

Publication Number Publication Date
JP2002527401A JP2002527401A (ja) 2002-08-27
JP2002527401A5 true JP2002527401A5 (https=) 2006-09-28

Family

ID=22298692

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000575522A Withdrawn JP2002527401A (ja) 1998-10-13 1999-10-13 Ｆｇｆの脈管形成的に有効な単位用量および投与方法
JP2010043385A Withdrawn JP2010174017A (ja) 1998-10-13 2010-02-26 Ｆｇｆの脈管形成的に有効な単位用量および投与方法
JP2013098522A Pending JP2013155193A (ja) 1998-10-13 2013-05-08 Ｆｇｆの脈管形成的に有効な単位用量および投与方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010043385A Withdrawn JP2010174017A (ja) 1998-10-13 2010-02-26 Ｆｇｆの脈管形成的に有効な単位用量および投与方法
JP2013098522A Pending JP2013155193A (ja) 1998-10-13 2013-05-08 Ｆｇｆの脈管形成的に有効な単位用量および投与方法

Country Status (5)

Country Link
US (4) US6451303B1 (https=)
EP (1) EP1121141A2 (https=)
JP (3) JP2002527401A (https=)
AU (1) AU6411199A (https=)
WO (1) WO2000021548A2 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618052B2 (en) 1998-10-13 2013-12-31 Novartis Vaccines And Diagnostics, Inc. Method of treating coronary artery disease by administering FGF-5
US20030166550A1 (en) * 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法
US6992066B2 (en) * 1998-10-16 2006-01-31 Zimmer Orthobiologics, Inc. Povidone-containing carriers for polypeptide growth factors
US7087577B2 (en) * 1998-10-16 2006-08-08 Zimmer Orthobiologies, Inc. Method of promoting natural bypass
JP5704780B2 (ja) * 1999-08-13 2015-04-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 脈管形成因子の用量および心筋血流を改善するための投与方法
US20040097996A1 (en) 1999-10-05 2004-05-20 Omnisonics Medical Technologies, Inc. Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode
US6551337B1 (en) 1999-10-05 2003-04-22 Omnisonics Medical Technologies, Inc. Ultrasonic medical device operating in a transverse mode
US6524251B2 (en) 1999-10-05 2003-02-25 Omnisonics Medical Technologies, Inc. Ultrasonic device for tissue ablation and sheath for use therewith
US20020115603A1 (en) 2000-06-22 2002-08-22 Chiron Corporation Methods and compositions for the treatment of peripheral artery disease
WO2002017956A2 (en) * 2000-08-31 2002-03-07 Chiron Corporation Stabilized fgf formulations containing reducing agents
WO2002077199A2 (en) * 2001-03-27 2002-10-03 Massachusetts Institute Of Technology Methods and products related to fgf dimerization
US20030139333A1 (en) * 2002-01-18 2003-07-24 Genetix Pharmaceuticals, Inc. Methods and compositions for promoting angiogenesis
AU2003279770A1 (en) * 2002-10-01 2004-04-23 Novartis Vaccines And Diagnostics, Inc. Anti-cancer and anti-infectious disease compositions and methods for using same
CN100579579C (zh) * 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
US7195598B2 (en) * 2003-05-23 2007-03-27 Siemens Aktiengesellschaft Method for determining the effectiveness of a medical therapy by analysis of collateral vessels
US7794414B2 (en) 2004-02-09 2010-09-14 Emigrant Bank, N.A. Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes
WO2006063132A2 (en) 2004-12-06 2006-06-15 The Regents Of The University Of California Methods for improving the structure and function of arterioles
WO2006081190A2 (en) * 2005-01-25 2006-08-03 Five Prime Therapeutics, Inc. Compositions and methods for treating cardiac conditions
US20100303793A1 (en) * 2007-04-10 2010-12-02 The Board Of Regents, The University Of Texas Syst Combination therapy for cardiac revascularization and cardiac repair
JP2011515471A (ja) * 2008-03-26 2011-05-19 オーソロジック コーポレイション 急性心筋梗塞を処置するための方法
EP2310039B1 (en) 2008-05-02 2014-07-16 University Of Western Ontario Fgf-9 and its use relating to blood vessels
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
TWI527590B (zh) * 2011-06-17 2016-04-01 艾瑞斯貿易公司 Ｆｇｆ－１８之凍乾調配物
US20140045751A1 (en) * 2012-08-10 2014-02-13 Florida State University Research Foundation Recombinant human fibroblast growth factor-1 as a novel therapeutic for ischemic diseases and methods thereof
CN108693179A (zh) * 2018-05-17 2018-10-23 郑州翱翔医药科技股份有限公司 一种药用丁基橡胶塞质量的快速鉴定方法
KR102273945B1 (ko) * 2019-12-31 2021-07-06 주식회사 알지프로나 인간섬유아세포성장인자 타입2 (hFGF2) 생산 발현용 벡터 및 상기 벡터로 형질전환된 미세조류
KR102283915B1 (ko) * 2019-12-31 2021-08-02 주식회사 알지프로나 인간섬유아세포성장인자 타입1 (hFGF1) 생산 발현용 벡터 및 상기 벡터로 형질전환된 미세조류

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296100A (en) 1980-06-30 1981-10-20 Franco Wayne P Method of treating the heart for myocardial infarction
US4378347A (en) * 1980-06-30 1983-03-29 Franco Wayne P Composition for treating the heart for myocardial infarction
US4956455A (en) 1984-03-05 1990-09-11 The Salk Institute For Biological Studies Bovine fibroblast growth factor
US5464774A (en) 1984-03-05 1995-11-07 The Salk Institute For Biological Studies Bovine basic fibroblast growth factor
US5155214A (en) 1984-03-05 1992-10-13 The Salk Institute For Biological Studies Basic fibroblast growth factor
US5604293A (en) 1985-09-12 1997-02-18 Scios Inc. Recombinant human basic fibroblast growth factor
US5439818A (en) 1985-09-12 1995-08-08 Scios Nova Inc. DNA encoding human recombinant basic fibroblast growth factor
US5238916A (en) 1987-05-29 1993-08-24 The Trustees Of Columbia University In The City Of New York Oncogene encoded polypeptide having growth factor activity and methods of use thereof
US5155217A (en) 1987-05-29 1992-10-13 The Trustees Of Columbia University In The City Of New York Ongogene encoding polypeptide having growth factor activity
US5750659A (en) 1987-06-16 1998-05-12 New York University Mammalian growth factor
WO1989004832A1 (en) 1987-11-24 1989-06-01 Amgen Inc. Analogs of fibroblast growth factor
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
AU614137B2 (en) 1988-06-06 1991-08-22 Takeda Chemical Industries Ltd. Stabilized fgf composition and production thereof
US5352589A (en) 1988-09-16 1994-10-04 Farmitalia Carlo Erba S.R.L. Deletion mutant of basic fibroblast growth factor and production thereof
US5137734A (en) 1989-03-22 1992-08-11 Dana Farber Cancer Institute Angiogenic monoglycerides
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
EP0421455B1 (en) * 1989-10-06 1995-04-05 Takeda Chemical Industries, Ltd. A mutein of HST-1 and production thereof
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
US5126323A (en) 1989-11-16 1992-06-30 Genetics Institute, Inc. Homogeneous purified k-fgf and compositions containing the same
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5206354A (en) 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
ES2087207T3 (es) 1990-11-23 1996-07-16 American Cyanamid Co Factor del crecimiento de fibroblasto quimerico.
US5213570A (en) 1990-12-14 1993-05-25 Mallinckrodt Medical, Inc. System and method for oxygenation of the pericardium
US5137510A (en) 1990-12-14 1992-08-11 Mallinckrodt Medical, Inc. System and method for oxygenation of the heart using subpericardial fluids
US5269326A (en) 1991-10-24 1993-12-14 Georgetown University Method for transvenously accessing the pericardial space via the right auricle for medical procedures
US5244460A (en) 1991-11-27 1993-09-14 The United States Of America As Represented By The Department Of Health And Human Services Method to foster myocardial blood vessel growth and improve blood flow to the heart
US5491220A (en) 1993-09-24 1996-02-13 Yeda Research And Development Co., Ltd. Surface loop structural analogues of fibroblast growth factors
US20030148968A1 (en) * 1995-02-28 2003-08-07 Hammond H. Kirk Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
US5792453A (en) 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
JP2000502682A (ja) * 1995-12-22 2000-03-07 ローカルメッド インコーポレイテッド 血管新生を促進する成長因子の局所的血管内デリバリー
DE69838526T2 (de) * 1998-02-05 2008-07-03 Biosense Webster, Inc., Diamond Bar Gerät zum Freisetzen eines Medikaments im Herzen
ES2233101T3 (es) 1998-09-03 2005-06-01 Chiron Corp Dosis unitaria de fgf-2 angiogenicamente efectiva y su utilizacion.
US20030166550A1 (en) * 1999-08-27 2003-09-04 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
US20020072489A1 (en) * 1998-10-13 2002-06-13 Whitehouse Martha J. Angiogenically effective unit dose of FGF-2 and method of use
US6440934B1 (en) * 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法

Similar Documents

Publication Publication Date Title
JP2002527401A5 (https=)
WO2000021548A3 (en) Angiogenically effective unit dose of fgf and method of administering
US5725852A (en) Transmucosal therapeutic composition
AU2019205905B2 (en) Improved peptide pharmaceuticals for treatment of NASH and other disorders
JP2550277B2 (ja) 過増殖性血管病の予防または治療用医薬組成物
JP4173913B2 (ja) Ｏｂタンパク質組成物を用いて血中脂質レベルを減少させ又は減少した血中脂質レベルを維持する方法
CA2302700A1 (en) New use for budesonide and formoterol
JP2002511385A5 (https=)
US20050048026A1 (en) Remedies for ischemic diseases
HUP0204459A2 (en) Method for the improvement of islet signaling in diabetes mellitus and for its prevention
WO2001013031A3 (en) Dose of an angiogenic factor and method of administering to improve myocardial blood flow
JP2002528502A5 (https=)
HU208635B (en) Process for production of stabilized medical preparatives containing fibroblast growing factor
MX2012002175A (es) Preparacion terapeutica para la rinitis.
JP2006516571A5 (https=)
RU2002130203A (ru) Пептидные конъюгаты для доставки лекарственного средства
JP2002523437A5 (https=)
JP2002530353A5 (https=)
JP2002524420A5 (https=)
JPH0399019A (ja) 毛細血管脆弱の処置の局所的使用のための製薬学的組成物
RU2002130719A (ru) Композиция, обладающая активирующей активностью
JP2011522875A (ja) 電気的除細動を予防するためのドロネダロン
WO2002058720A3 (en) Angiogenically effective unit dose of fgf-2 and method of use
AU6022399A (en) Angiogenically effective unit dose of fgf-2 and method of use
JPH11246433A (ja) 心筋梗塞治療剤